Viatris shares are trading higher after the company announced it plans to sell certain OTC products, its Women's Healthcare business, its Active Pharmaceutical Ingredients business in India and more.
Portfolio Pulse from Benzinga Newsdesk
Viatris has announced that it has received an offer for the divestiture of most of its OTC business. The company has also entered into definitive agreements to divest its Women's Healthcare business and API business in India. This has led to an increase in the company's share price.
October 02, 2023 | 12:37 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Viatris' decision to divest most of its OTC business and its Women's Healthcare and API businesses in India has led to an increase in its share price.
The divestiture of these businesses could potentially streamline Viatris' operations and improve its financial performance, which is likely why the company's share price has increased. However, the final impact will depend on the terms of the divestitures and how the company uses the proceeds.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100